Arvinas, Inc

ARVNNASDAQ • USD
NaN USD
↘ NaN (NaN%)🔴AT CLOSE (AS OF 03:45 AM EST)
🔴Market: CLOSED

Shares of Arvinas, Inc (ARVN) are trading at $NaN. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics suggest ARVN is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of Nov 16, 2026.

Open?N/A
High?N/A
Low?N/A
Prev. Close?$6.77
Volume?0
Avg. Volume?875.4K
Bid / Ask
Bid?$6.43 × 1.0K
Ask?$6.96 × 1.0K
Spread?$0.53
Midpoint?$6.70
Valuation & Ratios
Market Cap?443.3M
Shares Out?65.5M
Float?54.6M
Float %?84.7%
P/E Ratio?N/A
P/B Ratio?0.86
EPS?-$0.15
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Arvinas Inc is a clinical-stage biotechnology company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development, and commercialization of therapies that degrade disease-causing proteins. The company is using its PROteolysis TArgeting Chimera, a protein degradation platform, to develop therapeutics designed to harness the body's own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. Its clinical development program includes various product candidates such as ARV-102, ARV-806, ARV-393, ARV-027, and vepdegestrant, in their different stages of development, being developed to target certain harmful proteins causing oncology and neurology-related diseases.
Employees
246
Market Cap
446.6M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-09-27
Address
395 WINCHESTER AVE
NEW HAVEN, CT 06511
Phone: 203-535-1456
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
6
Momentum?
43
Short Sent.?
54
Piotroski F-Score?3/9Weak
Altman Z-Score?0.55Distress
Confidence?63%Moderate
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?10.53%High
Short Interest?5.8M
Days to Cover?7.6
Free Float54.6M
Avg Daily Volume757.5K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.39Strong
Quick Ratio?8.39Strong
Cash Ratio?1.26Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.86CHEAP▾
P/S?
Peers
100
S&P
76
1.61CHEAP▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-15.5CHEAP▾
EV/Sales?
Peers
100
S&P
87
1.29CHEAP▾
Returns & Efficiency
ROE?
S&P
14
-1.8%WEAK▾
ROA?
S&P
3
-1.6%WEAK▾
Cash Flow & Enterprise
FCF?$-159800000
Enterprise Value?$355.5M
Fundamentals ratios updated end of day